The TearLab success story began in 2007 when SCHOTT MINIFAB was approached to help turn the early stage eye health concept into a commercial product.
The relationship between TearLab and SCHOTT MINIFAB came at a pivotal moment. Prior to this partnership TearLab had invested considerable time and money with another developer / manufacturer only to be told that the concept was unworkable. Many other microfluidics experts had also voiced the opinion that the product was a technical impossibility.
Customers to benefit from complementary portfolio of top quality polymer and glass solutions for breakthrough diagnostics applications
SCHOTT AG, a leading international technology group in the areas of specialty glass and glass-ceramics, has entered into a purchase agreement to acquire the Australian microfluidic company MINIFAB Pty Ltd.
Minifab joins Emulate's collaborative community that is working to further develop and validate the Human Emulation System